Efficacy of polyherbal formulation along with standard care of treatment in early recovery of COVID-19 patients: a randomized placebo-controlled trial

被引：0
作者：
Abhishek Arun
Saumya Subramanian
Divya Kanchibhotla
机构：
[1] Atharva Multispeciality Hospital and Research Centre,
[2] Sri Sri Institute for Advanced Research,undefined
来源：
Beni-Suef University Journal of Basic and Applied Sciences | / 12卷
关键词：
COVID-19; NAOQ19; Polyherbal medicine; SARS-CoV-2; RT-PCR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial
    McMahon, James H.
    Lau, Jillian S. Y.
    Coldham, Anna
    Roney, Janine
    Hagenauer, Michelle
    Price, Sally
    Bryant, Mellissa
    Garlick, Jill
    Paterson, Anne
    Lee, Sue J.
    O'Bryan, Jess
    Hearps, Anna
    Tachedjian, Gilda
    Pinskier, Henry
    Phillips, Cameron
    Garrow, Stuart
    Pinskier, Nathan
    Melvin, Robert
    Blakeway, Luke
    Wisniewski, Jessica A.
    Byers, Sally
    Badoordeen, Gnei Z.
    Pereira, Stephanie
    Pragastis, Katherine
    Trubiano, Jason A.
    Chua, Kyra Y. L.
    Kainer, Marion
    Molton, James S.
    Gardiner, Bradley J.
    Pierce, Anna B.
    Cheng, Allen
    Rogers, Benjamin A.
    Peleg, Anton Y.
    ECLINICALMEDICINE, 2022, 54
  • [12] RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19
    Ajmera, Veeral
    Thompson, Wesley K.
    Smith, Davey M.
    Malhotra, Atul
    Mehta, Ravindra L.
    Tolia, Vaishal
    Yin, Jeffrey
    Sriram, Krishna
    Insel, Paul A.
    Collier, Summer
    Richards, Lisa
    Loomba, Rohit
    CONTEMPORARY CLINICAL TRIALS, 2021, 103
  • [13] Efficacy and safety of aniseed powder for treating gastrointestinal symptoms of COVID-19: a randomized, placebo-controlled trial
    Mosaffa-Jahromi, Maryam
    Vardanjani, Hossein Molavi
    Fuzimoto, Andrea
    Hunter, Jennifer
    Lankarani, Kamran Bagheri
    Pasalar, Mehdi
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [14] Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial
    Tobback, Els
    Degroote, Sophie
    Buysse, Sabine
    Delesie, Liesbeth
    Van Dooren, Lucas
    Vanherrewege, Sophie
    Barbezange, Cyril
    Hutse, Veronik
    Romano, Marta
    Thomas, Isabelle
    Padalko, Elizaveta
    Callens, Steven
    De Scheerder, Marie-Angelique
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 : 628 - 635
  • [15] Amantadine in unvaccinated patients with early, mild to moderate COVID-19: A randomized, placebo-controlled, double-blind trial
    Rejdak, Konrad
    Fiedor, Piotr
    Bonek, Robert
    Lukasiak, Jacek
    Chelstowski, Waldemar
    Kiciak, Slawomir
    Dabrowski, Piotr
    Gala-Bladzinska, Agnieszka
    Dec, Mateusz
    Papuc, Ewa
    Zasybska, Adriana
    Kaczor, Marcin
    Grieb, Pawel
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (01)
  • [16] Sulodexide in the Treatment of Patients with Early Stages of COVID-19: A Randomized Controlled Trial
    Gonzalez-Ochoa, Alejandro J.
    Raffetto, Joseph D.
    Hernandez, Ana G.
    Zavala, Nestor
    Gutierrez, Obed
    Vargas, Arturo
    Loustaunau, Jorge
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (07) : 944 - 954
  • [17] Efficacy of probiotic treatment as post-exposure prophylaxis for COVID-19: A double-blind, Placebo-Controlled Randomized trial
    Wischmeyer, Paul E.
    Tang, Helen
    Ren, Yi
    Bohannon, Lauren
    Jiang, Danting
    Bergens, Matthew
    Ramirez, Zeni E.
    Andermann, Tessa M.
    Messina, Julia A.
    Sung, Julia A.
    Jensen, David
    Jung, Sin-Ho
    Artica, Alexandra
    Britt, Anne
    Bush, Amy
    Johnson, Ernaya
    V. Lew, Meagan
    Winthrop, Hilary
    Pamanes, Claudia
    Racioppi, Alessandro
    Zhao, Aaron T.
    Wan, Zihan
    Surana, Neeraj K.
    Sung, Anthony D.
    CLINICAL NUTRITION, 2024, 43 (01) : 259 - 267
  • [18] A Randomized Placebo-Controlled Trial of Leronlimab in Mild-To-Moderate COVID-19
    Seethamraju, Harish
    Yang, Otto O.
    Loftus, Richard
    Ogbuagu, Onyema
    Sammartino, Daniel
    Mansour, Ali
    Sacha, Jonah B.
    Ojha, Sohita
    Hansen, Scott G.
    Arman, Arvin Cyrus
    Lalezari, Jacob P.
    CLINICAL THERAPEUTICS, 2024, 46 (11) : 891 - 899
  • [19] Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial
    Jain, Mamta K.
    De Lemos, James A.
    McGuire, Darren K.
    Ayers, Colby.
    Eitson, Jennifer L.
    Sanchez, Claudia L.
    Kamel, Dena
    Meisner, Jessica A.
    Thomas, Emilia V.
    Hegde, Anita A.
    Mocherla, Satish
    Strebe, Joslyn K.
    Li, Xilong
    Williams, Noelle S.
    Xing, Chao
    Ahmed, Mahmoud S.
    Wang, Ping
    Sadek, Hesham A.
    Schoggins, John W.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [20] Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Daniel Q. Huang
    Veeral Ajmera
    Christian Tomaszewski
    Andrew LaFree
    Ricki Bettencourt
    Wesley K. Thompson
    Davey M. Smith
    Atul Malhotra
    Ravindra L. Mehta
    Vaishal Tolia
    Jeffrey Yin
    Paul A. Insel
    Stone Leachman
    Jinho Jung
    Summer Collier
    Lisa Richards
    Kristin Woods
    Maral Amangurbanova
    Archana Bhatt
    Xinlian Zhang
    Oana M. Penciu
    Stuart Zarich
    Tamrat Retta
    Michelle S. Harkins
    J. Pedro Teixeira
    Brian Chinnock
    Netanya S. Utay
    Jordan E. Lake
    Rohit Loomba
    Advances in Therapy, 2023, 40 : 4805 - 4816
12345